1. Home
  2. HALO vs CHYM Comparison

HALO vs CHYM Comparison

Compare HALO & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$100.98

Market Cap

14.8B

Sector

Health Care

ML Signal

N/A

Logo Chime Financial Inc.

CHYM

Chime Financial Inc.

N/A

Current Price

$32.85

Market Cap

12.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
CHYM
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
12.0B
IPO Year
2001
2025

Fundamental Metrics

Financial Performance
Metric
HALO
CHYM
Price
$100.98
$32.85
Analyst Decision
Buy
Strong Buy
Analyst Count
9
23
Target Price
★ $119.89
$41.90
AVG Volume (30 Days)
2.3M
★ 3.6M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 5.12
0.31
Revenue
$151,862,000.00
★ $2,186,770,000.00
Revenue This Year
$35.97
$28.06
Revenue Next Year
$14.85
$23.18
P/E Ratio
★ $19.84
$106.56
Revenue Growth
N/A
★ 30.69
52 Week Low
$61.23
$15.88
52 Week High
$134.00
$35.55

Technical Indicators

Market Signals
Indicator
HALO
CHYM
Relative Strength Index (RSI) 27.51 66.54
Support Level $64.08 $30.95
Resistance Level $111.15 $33.41
Average True Range (ATR) 4.64 1.30
MACD -3.78 0.47
Stochastic Oscillator 6.04 90.41

Price Performance

Historical Comparison
HALO
CHYM

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CHYM Chime Financial Inc.

Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.

Share on Social Networks: